Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/193482
Title: | Monitoring emergence of SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARSCoV-2 Wastewater Surveillance System (VATar COVID-19) from December 2020 to March 2021 |
Author: | Carcereny, Albert Martínez-Velázquez, Adán Bosch, Albert Allende, Anna Truchado, Pilar Cascales, Jenifer Romalde, Jesús Lois, Marta Polo, David Sánchez, Gloria Pérez-Cataluña, Alba Díaz-Reolid, Azahara Antón, Andrés Gregor, Josep Garcia-Cehic, Damir Quer, Josep Palau, Margarita González Ruano, Cristina Pintó Solé, Rosa María Guix, Susana |
Keywords: | SARS-CoV-2 COVID-19 Epidemiologia SARS-CoV-2 COVID-19 Epidemiology |
Issue Date: | 2021 |
Publisher: | American Chemical Society |
Abstract: | Since its first identification in the United Kingdom in late 2020, the highly transmissible B.1.1.7 variant of SARS-CoV-2 has become dominant in several countries raising great concern. We developed a duplex real-time RT-qPCR assay to detect, discriminate, and quantitate SARS-CoV-2 variants containing one of its mutation signatures, the ΔHV69/70 deletion, and used it to trace the community circulation of the B.1.1.7 variant in Spain through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19). The B.1.1.7 variant was detected earlier than clinical epidemiological reporting by the local authorities, first in the southern city of Málaga (Andalucía) in week 20_52 (year_week), and multiple introductions during Christmas holidays were inferred in different parts of the country. Wastewater-based B.1.1.7 tracking showed a good correlation with clinical data and provided information at the local level. Data from wastewater treatment plants, which reached B.1.1.7 prevalences higher than 90% for ≥2 consecutive weeks showed that 8.1 ± 2.0 weeks were required for B.1.1.7 to become dominant. The study highlights the applicability of RT-qPCR-based strategies to track specific mutations of variants of concern as soon as they are identified by clinical sequencing and their integration into existing wastewater surveillance programs, as a cost-effective approach to complement clinical testing during the COVID-19 pandemic. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1021/acs.est.1c03589 |
It is part of: | Environmental Science & Technology, 2021, vol. 55, num. 17, p. 11756-11766 |
URI: | https://hdl.handle.net/2445/193482 |
Related resource: | https://doi.org/10.1021/acs.est.1c03589 |
ISSN: | 0013-936X |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
719030.pdf | 1.23 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.